Cyclosporin a potentiates receptor-activated [Ca2+](C) increase

Journal of Receptor and Signal Transduction Research

Volumn 17, Issue 1-3, 1997, Pages 149-161

  Lo Russo, A ^a   Passaquin, A C ^a   Cox, C ^a   Ruegg U T ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ARGIPRESSIN; CALCINEURIN; CALCIUM; CYCLOPHILIN; CYCLOSPORIN A; ENDOTHELIN 1; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL PHOSPHATE; SEROTONIN;

ANIMAL CELL; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONFERENCE PAPER; DRUG POTENTIATION; DRUG RECEPTOR BINDING; HYPERTENSION; NONHUMAN; RAT; SMOOTH MUSCLE FIBER; VASOCONSTRICTION;

EID: 0031034325     PISSN: 10799893     EISSN: None     Source Type: Journal    
DOI: 10.3109/10799899709036600     Document Type: Conference Paper

References (25)

1. Garr M.D. and Paller, M.S. Cyclosporine augments renal but not systemic vascular reactivity. Am. J. Physiol. 258, F211-F217, 1990.
2. Scherrer, U., Vissing, S.F., Morgan, B.J., Rollins, J.A., Tindall, R.S., Ring, S., Hanson, P., Mohanty, P.K. and Victor, R.G. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N. Engl. J. Med. 693-699, 1990.
3. Textor, S.C., Canzanello, V.J., Taler, S.J., Wilson, D.J., Schwartz L.L. Augustine J.E., Raymer, J.M., Romero, J.C., Wiesner, R.H., Krom, R.A. and et al Cycloporine-induced hypertension after transplantation. Mayo Clinic. Proceedings, 69, 1182-1193, 1994.
4. Lyson, T., McMullan, D.M., Ermel, L.D., Morgan, B.J. and Victor, R.G. Mechanism of cyclosporine-induced sympathetic activation and acute hypertension in rats. Hypertension, 23, 667-675, 1994.
5. Julien, J., Farge, D., Kreft-Jais, C., Guyene, T.T., Plouin, P.F., Houssin, D., Carpentier, A. and Corvol, P. Cyclosporine-induced stimulation of the renin-agiotensin system after liver and heart transplantation. Transplantation, 56, 885-891, 1993.
6. Diederich, D., Skopec, J., Diederich, A. and Dai, F.X. Cyclosporine produces endothelial dysfunction by increased production of superoxide. Hypertension, 23, 957-961, 1994.
7. Roullet, J.B., Xue, H., McCarron, D.A., Holcomb, S. and Bennett, W.M. Vascular mechanisms of cyclosporin-induced hypertension in the rat. J. Clin. Invest. 93, 2244-2250, 1994.
8. Grieff, M., Loertscher, R., Shohaib, S.A. and Stewart, D.J. Cyclosporine-induced elevation in circulating endothelin-1 in patients with solid-organ transplants. Transplantation, 56, 880-884, 1993.
9. 2 receptor antagonists on cyclosporin A renal vasoconstriction. Am. J. Physiol., 267, F443-F449, 1994.
10. Iwai, J., Kanayama, Y., Inoue, N.N., Okamura, M. and Takeda, T. Increased endothelial gene expression of angiotensin AT1A receptor in cyclosporine induced hypertensive rats. Eur. J. of Pharmacol., 248, 341-344, 1993.
11. Iwai, J., Kanayama, Y., Negoro, N., Inoue, T., Okamura, M. and Takeda, T. Increased gene expression of angiotensin II type 1A receptor in aortic smooth muscle cells of cyclosporin A-induced hypertensive rats. J. Hypertens. 11, S122-S123, 1993.
12. Mason, J. Pharmacology of cyclosporine (sandimmune). VII. Pathophysiology and toxicology of cyclosporine in humans and animals. Pharmacol. Rev. 41, 423-434, 1990.
13. Feutren, G. and Mihatsch, M.J. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases. N. Engl. J. Med. 326, 1654-1660, 1992.
14. Pfeuschifter, J. and Rüegg, U.T. Cyclosporin A augments angiotensin II-stimulated rise in intracellular free calcium in vascular smooth muscle cells. Biochem. J. 248, 883-887, 1987.
15. Lo Russo, A., Passaquin, A.C., André, P., Skutella, M. and Rüegg, U.T. (1996) Effect of cyclosporin A and analogues on cytosolic calcium and vasoconstriction: lack of relationships to immunosuppression. Br. J. Pharmacol. In Press.
16. Berridge, M.J. Inositol trisphosphate and calcium signalling. Nature, 361, 315-325, 1993.
17. Knot, H.J., de Ree, M.M., Gähwiler, B.H. and Rüegg, U.T. Modulation of electrical activity and of intracellular calcium oscillations of smooth muscle cells by calcium antagonists, agonists, and vasopressin. J. Cardiovasc. Pharmacol. 18, S7-14, 1991.
18. 2+ indicators with greatly unproved fluorescence properties., J. Biol. Chem. 260, 3440-3450, 1985.
19. Antonny, B., Sukumar, M., Bigay, J., Chabre, M. and Higashijima, T. The mechanism of aluminum-independent G-protein activation by fluoride and magnesium. 31P NMR spectroscopy and fluorescence kinetic studies. J. Biol. Chem. 268, 2393-2402, 1993.
20. Schreiber, S.L. and Crabtree, G.R. The mechanism of action of cyclosporin A and FK506. Immunol. Today, 13, 136-142, 1992.
21. 2+ homeostasis in vascular smooth muscle. Journal of Vascular Research, 32, 207-219, 1995.
22. Wenger, R.M., Payne, T.G. and Schreier, M.H. Cyclosporine: chemistry, structure-activity relationships and mode of action, Prog. Clin. Biochem. and Med. 3, 157-191, 1986.
23. McNally, P.G., Heagerty, A.M., Walls, J. and Feehally, J. Phosphoinositide hydrolysis is not enhanced by ciclosporin. Nephron, 59, 512-514, 1991.
24. Nambi, P., Pullen, M., Contino, L.C. and Brooks, D.P. Upregulation of renal endothelin receptors in rats with cyclosporine A-induced nephrotoxicity. Eur. J. Pharmacol. 187, 113-116, 1990.
25. Tufro-McReddie, A., Gomez, R.A., Norling, L.L., Omar, A.A., Moore, L.C. and Kaskel, F. J. Effect of CsA on the expression of renin and angiotensin type 1 receptor genes in the rat kidney. Kidney Int. 43, 615-622, 1993.